Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification

A. De Luca, I. Bottillo, M. C. Dasdia, A. Morella, V. Lanari, L. Bernardini, L. Divona, S. Giustini, L. Sinibaldi, A. Novelli, I. Torrente, A. Schirinzi, Bruno Dallapiccola

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

To estimate the contribution of single and multi-exon NF1 gene copy-number changes to the NF1 mutation spectrum, we analysed a series of 201 Italian patients with neurofibromatosis type 1 (NF1). Of these, 138 had previously been found, using denaturing high-performance liquid chromatography or protein truncation test, to be heterozygous for intragenic NF1 point mutations/deletions/insertions, and were excluded from this analysis. The remaining 63 patients were analysed using multiplex ligation-dependent probe amplification (MLPA), which allows detection of deletions or duplications encompassing ≥1 NF1 exons, as well as entire gene deletions. MLPA results were validated using real-time quantitative PCR (qPCR) or fluorescent in situ hybridisation. MLPA screening followed by real-time qPCR detected a total of 23 deletions. Of these deletions, six were single exon, eight were multi-exon, and nine were of the entire NF1 gene. In our series, deletions encompassing ≥1 NF1 exons accounted for ∼7% (14/201) of the NF1 gene mutation spectrum, suggesting that screening for these should now be systematically included in genetic testing of patients with NF1.

Original languageEnglish
Pages (from-to)800-808
Number of pages9
JournalJournal of Medical Genetics
Volume44
Issue number12
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Neurofibromatosis 1 Genes
Neurofibromatosis 1
Multiplex Polymerase Chain Reaction
Exons
Real-Time Polymerase Chain Reaction
Mutation
Gene Dosage
Gene Deletion
Genetic Testing
Fluorescence In Situ Hybridization
Point Mutation
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. / De Luca, A.; Bottillo, I.; Dasdia, M. C.; Morella, A.; Lanari, V.; Bernardini, L.; Divona, L.; Giustini, S.; Sinibaldi, L.; Novelli, A.; Torrente, I.; Schirinzi, A.; Dallapiccola, Bruno.

In: Journal of Medical Genetics, Vol. 44, No. 12, 12.2007, p. 800-808.

Research output: Contribution to journalArticle

De Luca, A, Bottillo, I, Dasdia, MC, Morella, A, Lanari, V, Bernardini, L, Divona, L, Giustini, S, Sinibaldi, L, Novelli, A, Torrente, I, Schirinzi, A & Dallapiccola, B 2007, 'Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification', Journal of Medical Genetics, vol. 44, no. 12, pp. 800-808. https://doi.org/10.1136/jmg.2007.053785
De Luca, A. ; Bottillo, I. ; Dasdia, M. C. ; Morella, A. ; Lanari, V. ; Bernardini, L. ; Divona, L. ; Giustini, S. ; Sinibaldi, L. ; Novelli, A. ; Torrente, I. ; Schirinzi, A. ; Dallapiccola, Bruno. / Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. In: Journal of Medical Genetics. 2007 ; Vol. 44, No. 12. pp. 800-808.
@article{811642d1d920411da9b7cc64d466f7bc,
title = "Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification",
abstract = "To estimate the contribution of single and multi-exon NF1 gene copy-number changes to the NF1 mutation spectrum, we analysed a series of 201 Italian patients with neurofibromatosis type 1 (NF1). Of these, 138 had previously been found, using denaturing high-performance liquid chromatography or protein truncation test, to be heterozygous for intragenic NF1 point mutations/deletions/insertions, and were excluded from this analysis. The remaining 63 patients were analysed using multiplex ligation-dependent probe amplification (MLPA), which allows detection of deletions or duplications encompassing ≥1 NF1 exons, as well as entire gene deletions. MLPA results were validated using real-time quantitative PCR (qPCR) or fluorescent in situ hybridisation. MLPA screening followed by real-time qPCR detected a total of 23 deletions. Of these deletions, six were single exon, eight were multi-exon, and nine were of the entire NF1 gene. In our series, deletions encompassing ≥1 NF1 exons accounted for ∼7{\%} (14/201) of the NF1 gene mutation spectrum, suggesting that screening for these should now be systematically included in genetic testing of patients with NF1.",
author = "{De Luca}, A. and I. Bottillo and Dasdia, {M. C.} and A. Morella and V. Lanari and L. Bernardini and L. Divona and S. Giustini and L. Sinibaldi and A. Novelli and I. Torrente and A. Schirinzi and Bruno Dallapiccola",
year = "2007",
month = "12",
doi = "10.1136/jmg.2007.053785",
language = "English",
volume = "44",
pages = "800--808",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification

AU - De Luca, A.

AU - Bottillo, I.

AU - Dasdia, M. C.

AU - Morella, A.

AU - Lanari, V.

AU - Bernardini, L.

AU - Divona, L.

AU - Giustini, S.

AU - Sinibaldi, L.

AU - Novelli, A.

AU - Torrente, I.

AU - Schirinzi, A.

AU - Dallapiccola, Bruno

PY - 2007/12

Y1 - 2007/12

N2 - To estimate the contribution of single and multi-exon NF1 gene copy-number changes to the NF1 mutation spectrum, we analysed a series of 201 Italian patients with neurofibromatosis type 1 (NF1). Of these, 138 had previously been found, using denaturing high-performance liquid chromatography or protein truncation test, to be heterozygous for intragenic NF1 point mutations/deletions/insertions, and were excluded from this analysis. The remaining 63 patients were analysed using multiplex ligation-dependent probe amplification (MLPA), which allows detection of deletions or duplications encompassing ≥1 NF1 exons, as well as entire gene deletions. MLPA results were validated using real-time quantitative PCR (qPCR) or fluorescent in situ hybridisation. MLPA screening followed by real-time qPCR detected a total of 23 deletions. Of these deletions, six were single exon, eight were multi-exon, and nine were of the entire NF1 gene. In our series, deletions encompassing ≥1 NF1 exons accounted for ∼7% (14/201) of the NF1 gene mutation spectrum, suggesting that screening for these should now be systematically included in genetic testing of patients with NF1.

AB - To estimate the contribution of single and multi-exon NF1 gene copy-number changes to the NF1 mutation spectrum, we analysed a series of 201 Italian patients with neurofibromatosis type 1 (NF1). Of these, 138 had previously been found, using denaturing high-performance liquid chromatography or protein truncation test, to be heterozygous for intragenic NF1 point mutations/deletions/insertions, and were excluded from this analysis. The remaining 63 patients were analysed using multiplex ligation-dependent probe amplification (MLPA), which allows detection of deletions or duplications encompassing ≥1 NF1 exons, as well as entire gene deletions. MLPA results were validated using real-time quantitative PCR (qPCR) or fluorescent in situ hybridisation. MLPA screening followed by real-time qPCR detected a total of 23 deletions. Of these deletions, six were single exon, eight were multi-exon, and nine were of the entire NF1 gene. In our series, deletions encompassing ≥1 NF1 exons accounted for ∼7% (14/201) of the NF1 gene mutation spectrum, suggesting that screening for these should now be systematically included in genetic testing of patients with NF1.

UR - http://www.scopus.com/inward/record.url?scp=37249043142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249043142&partnerID=8YFLogxK

U2 - 10.1136/jmg.2007.053785

DO - 10.1136/jmg.2007.053785

M3 - Article

VL - 44

SP - 800

EP - 808

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 12

ER -